Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evert Bosdriesz

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molecular & Cellular Proteomics : MCP|February 18, 2026
Cell-state specific drug-responses are associated with differences in signaling network wiringNiels Krämer, Roderick van Eijl, Tim Stohn, et al.
Genome Medicine|February 11, 2021
Correction to: A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancersTonći Šuštić, Sake van Wageningen, Evert Bosdriesz, et al.
Genome Medicine|November 29, 2018
A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancersTonći Šuštić, Sake van Wageningen, Evert Bosdriesz, et al.
Cell Research|May 26, 2018
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer modelsZheng Xue, Daniel J Vis, Alejandra Bruna, et al.
Molecular & Cellular Proteomics : MCP|July 5, 2018
A System-wide Approach to Monitor Responses to Synergistic BRAF and EGFR Inhibition in Colorectal Cancer CellsAnna Ressa, Evert Bosdriesz, Joep de Ligt, et al.
Cell|May 15, 2018
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic PotentialLiqin Wang, Rodrigo Leite de Oliveira, Sanne Huijberts, et al.
Nature Communications|June 24, 2020
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumoursJoão M Fernandes Neto, Ernest Nadal, Evert Bosdriesz, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular & Cellular Proteomics : MCP|February 18, 2026
Cell-state specific drug-responses are associated with differences in signaling network wiringNiels Krämer, Roderick van Eijl, Tim Stohn, et al.
Genome Medicine|February 11, 2021
Correction to: A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancersTonći Šuštić, Sake van Wageningen, Evert Bosdriesz, et al.
Genome Medicine|November 29, 2018
A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancersTonći Šuštić, Sake van Wageningen, Evert Bosdriesz, et al.
Cell Research|May 26, 2018
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer modelsZheng Xue, Daniel J Vis, Alejandra Bruna, et al.
Molecular & Cellular Proteomics : MCP|July 5, 2018
A System-wide Approach to Monitor Responses to Synergistic BRAF and EGFR Inhibition in Colorectal Cancer CellsAnna Ressa, Evert Bosdriesz, Joep de Ligt, et al.
Cell|May 15, 2018
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic PotentialLiqin Wang, Rodrigo Leite de Oliveira, Sanne Huijberts, et al.
Nature Communications|June 24, 2020
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumoursJoão M Fernandes Neto, Ernest Nadal, Evert Bosdriesz, et al.
Pageof 2